Report copyright - Lippincott Williams & Wilkins · Web viewOutcome Reference Tested therapy Comparisons, n Relative Risk 95% LCL 95% UCL I² GnRH agonist GnRH antagonist 1 0.55 0.22 1.32 AA Estrogen
Please pass captcha verification before submit form